Management of Influenza in Adults Older than 65 Years of Age: Cost-Effectiveness of Rapid Testing and Antiviral Therapy
about
sameAs
Cost effectiveness of oseltamivir treatment for patients with influenza-like illness who are at increased risk for serious complications of influenza: illustration for the Netherlands.Novel strategies for prevention and treatment of influenza.Influenza testing, diagnosis, and treatment in the emergency department in 2009-2010 and 2010-2011Use of molecular assays for the diagnosis of influenza.Antiviral treatment among older adults hospitalized with influenza, 2006-2012Economic value of seasonal and pandemic influenza vaccination during pregnancy.Antiviral medications for pregnant women for pandemic and seasonal influenza: an economic computer model.The impact of pandemic influenza H1N1 on health-related quality of life: a prospective population-based studyInfluenza outbreak during Sydney World Youth Day 2008: the utility of laboratory testing and case definitions on mass gathering outbreak containment.The potential cost-effectiveness of quadrivalent versus trivalent influenza vaccine in elderly people and clinical risk groups in the UK: a lifetime multi-cohort model.Cost-utility of rapid polymerase chain reaction-based influenza testing for high-risk emergency department patients.Aging exacerbates damage and delays repair of alveolar epithelia following influenza viral pneumonia.From the patient perspective: the economic value of seasonal and H1N1 influenza vaccination.Amantadine for adynamic speech: possible benefit for aphasia?National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: V. The 2014 Ancillary Therapy and Supportive Care Working Group Report.Use of rapid tests and antiviral medications for influenza among primary care providers in the United StatesAntiviral and antibiotic prescribing for influenza in primary careEconomics of influenza vaccine administration timing for children.The timing of influenza vaccination for older adults (65 years and older).Reducing the burden of influenza-associated complications with antiviral therapy.A systematic review of clinical decision rules for the diagnosis of influenzaAppropriateness of antiviral prescribing for influenza in primary care: a retrospective analysis.Cost-effectiveness analysis of quadrivalent versus trivalent influenza vaccine in Taiwan: A lifetime multi-cohort modelA novel approach to the determination of clinical decision thresholds.Effects of local variation, specialty, and beliefs on antiviral prescribing for influenza.Rapid Tests for Influenza.Cost-effectiveness analysis of different seasonal influenza vaccines in the elderly Italian population.
P2860
Q30229855-3B38B89C-0402-45E5-98C0-D6C83D2A0DDEQ30350342-2FCAA18D-9F80-4862-A2D2-51115FA1B0A6Q30353587-D7476E7C-A39D-4745-9930-1A6B0D4D36EDQ30359548-503ECEA8-75C1-4C21-AAC9-5822FA3839A8Q30373020-1FA985F6-A6B7-4983-978D-68D96A8F30A4Q30382520-E2ED0B1C-5F27-4A54-BEFC-47B93744A174Q30385821-304ADC99-D2AE-4BEB-9728-CD610BE0F256Q30400700-6B61B2B6-3B3A-40F7-9873-CB8B51865118Q33499697-7ADF1F01-B183-4945-BF8C-0A2DB87751D5Q33721397-BAB1D3C0-D6C8-4EB0-9A60-E1AADB1F8216Q34171619-54546945-02E7-4B89-B66C-C0B4285B5E53Q34306034-1E661E5F-75B7-447D-9413-8FDEF202C528Q34613417-58ED87C0-8435-422F-8B43-900C45F76085Q35925206-73484FF7-51A1-4BC7-A459-AB11821DC335Q36766324-DCCFCB2D-B9BA-4C06-97FA-5151585C421FQ37087704-1DB2A608-5B6B-4D33-AE8F-51BAB9C0D718Q37136683-530B086A-C54B-44A7-BF3F-2534E128D019Q37147657-37764421-60E7-4ED4-BB2D-FBDD7627849CQ37437954-0B6646D3-6907-4898-ACC4-0D11FE248897Q37496797-154A8260-E726-4227-A4F4-9ED5EC6DE702Q37829591-3790DCAD-36DA-462E-8A43-A22FEA59FDF2Q40476247-A00D2C40-EBA8-4D2B-9614-4BEF989D3E24Q40582993-F051CFDD-5980-49A4-BC95-8AB14ABF4157Q41307375-8B391654-8A38-4CD5-A8B5-9AFAE7E69365Q47236608-E4FE0ECF-E21A-4562-8FEC-F9B8F7D37940Q47809619-DB79631F-4468-4003-B8E5-50E70270B701Q48504278-2E44CFC8-3919-4501-A476-9B1E23761A90
P2860
Management of Influenza in Adults Older than 65 Years of Age: Cost-Effectiveness of Rapid Testing and Antiviral Therapy
description
2003 nî lūn-bûn
@nan
2003 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Management of Influenza in Adu ...... Testing and Antiviral Therapy
@ast
Management of Influenza in Adu ...... Testing and Antiviral Therapy
@en
Management of Influenza in Adu ...... Testing and Antiviral Therapy
@en-gb
type
label
Management of Influenza in Adu ...... Testing and Antiviral Therapy
@ast
Management of Influenza in Adu ...... Testing and Antiviral Therapy
@en
Management of Influenza in Adu ...... Testing and Antiviral Therapy
@en-gb
altLabel
Management of influenza in adu ...... testing and antiviral therapy.
@ast
Management of influenza in adu ...... testing and antiviral therapy.
@en
prefLabel
Management of Influenza in Adu ...... Testing and Antiviral Therapy
@ast
Management of Influenza in Adu ...... Testing and Antiviral Therapy
@en
Management of Influenza in Adu ...... Testing and Antiviral Therapy
@en-gb
P2093
P1476
Management of Influenza in Adu ...... Testing and Antiviral Therapy
@en
Management of influenza in adu ...... testing and antiviral therapy.
@en
P2093
David N Rose
Michael B Rothberg
Michael B. Rothberg
Sandra Bellantonio
P356
10.7326/0003-4819-139-5_PART_1-200309020-00007
P407
P577
2003-09-01T00:00:00Z
2003-09-02T00:00:00Z